FDA.reportPublic FDA data

ozanimod 37-Day Starter Kit

RxCUI
2288430
RxNorm name
ozanimod 37-Day Starter Kit
Display name
ozanimod 37-Day Starter Kit
Full name
ozanimod 37-Day Starter Kit
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZEPOSIA 7-Day Starter PackOZANIMOD HYDROCHLORIDECelgene Corporation93ce2fab-edfb-4804-8074-963071de51e42026-04-16Warnings, Adverse reactionsExact identifier
rxcui: 2288430

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
93ce2fab-edfb-4804-8074-963071de51e4{4 (ozanimod 0.23 MG Oral Capsule) / 3 (ozanimod 0.46 MG Oral Capsule) / 30 (ozanimod 0.92 MG Oral Capsule) } Pack [GPCK] · ozanimod 37-Day Starter Kit [PSN] · ozanimod 37-Day Starter Kit (7-Day Starter Pack and 0.92 MG 30 count Bottle) [SY]325These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 202020260416